| Literature DB >> 32139596 |
Jinhong Sun1, Yi Xiong1, Xin Li2, Leena Haataja1, Wei Chen1,3, Saiful A Mir4, Li Lv2, Rachel Madley1, Dennis Larkin1, Arfah Anjum1, Balamurugan Dhayalan5, Nischay Rege6, Nalinda P Wickramasinghe6, Michael A Weiss5, Pamela Itkin-Ansari4,7, Randal J Kaufman8, David A Ostrov9, Peter Arvan10, Ming Liu10,2.
Abstract
Abnormal interactions between misfolded mutant and wild-type (WT) proinsulin (PI) in the endoplasmic reticulum (ER) drive the molecular pathogenesis of mutant INS gene-induced diabetes of youth (MIDY). How these abnormal interactions are initiated remains unknown. Normally, PI-WT dimerizes in the ER. Here, we suggest that the normal PI-PI contact surface, involving the B-chain, contributes to dominant-negative effects of misfolded MIDY mutants. Specifically, we find that PI B-chain tyrosine-16 (Tyr-B16), which is a key residue in normal PI dimerization, helps confer dominant-negative behavior of MIDY mutant PI-C(A7)Y. Substitutions of Tyr-B16 with either Ala, Asp, or Pro in PI-C(A7)Y decrease the abnormal interactions between the MIDY mutant and PI-WT, rescuing PI-WT export, limiting ER stress, and increasing insulin production in β-cells and human islets. This study reveals the first evidence indicating that noncovalent PI-PI contact initiates dominant-negative behavior of misfolded PI, pointing to a novel therapeutic target to enhance PI-WT export and increase insulin production.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32139596 PMCID: PMC7171958 DOI: 10.2337/db19-1106
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461